arginine has been researched along with Brill-Symmers Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (46.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Calaminici, M; Carlotti, E; Fitzgibbon, J; Gribben, J; Iqbal, S; Lister, TA; Matthews, J; Waters, R; Wrench, D | 1 |
| Audhuy, B; Bachy, E; Belhadj, K; Brice, P; Brousse, N; Cartron, G; Delwail, V; Fermé, C; Feugier, P; Foussard, C; Houot, R; Le Gouill, S; Lefort, S; Maisonneuve, H; Morschhauser, F; Salles, G; Sebban, C; Sonet, A | 1 |
| Ma, X; Ren, C; Sheng, Z; Wang, B; Xia, B; Zhang, W | 1 |
| Enschede, SH; Gregory, SA; Porter, C; Venugopal, P | 1 |
| Belanger, C; Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Doyen, C; Feugier, P; Haioun, C; Mounier, N; Salles, G; Sebban, C; Tilly, H | 1 |
| Morrison, VA | 1 |
| Brousse, N; Canioni, D; Foussard, C; Keuppens, M; Lamy, T; Morchhauser, F; Mounier, N; Rousselet, MC; Salles, G; Sonet, A; Xerri, L | 1 |
| Bastion, Y; Brice, P; Coiffier, B; Espinouse, D; Gisselbrecht, C; Haioun, C; Marolleau, JP; Reyes, F; Salles, G; Sonet, A | 1 |
| Bosly, A; Brice, P; Brousse, N; Haioun, C; Lepage, E; Leporrier, M; Parlier, Y; Peuchmaur, M; Reyes, F; Solal-Celigny, P | 1 |
| Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Doyen, C; Gabarre, J; Haïoun, C; Lepage, E; Pignon, B; Rossi, JF; Solal-Céligny, P; Tendler, CL; Tertian, G | 1 |
| Cole, BF; Gelber, RD; Gisselbrecht, C; Goldhirsch, A; Lepage, E; Reyes, F; Sebban, C; Solal-Céligny, P; Sugano, D; Tendler, C | 1 |
| Belhadj, K; Brice, P; Brousse, N; Chèze, S; Coiffier, B; Decaudin, D; Harousseau, JL; Lepage, E; Michaux, L; Solal-Céligny, P; Tilly, H | 1 |
| Belanger, C; Bouabdallah, R; Brice, P; Brousse, N; Coiffier, B; Haioun, C; Janvier, M; Neidhardt-Bérard, EM; Péaud, PY; Pico, JL; Solal-Celigny, P; Tilly, H | 1 |
| Fezoui, H; Genet, P; Lionnet, F; Louvel, D; Pulik, M; Touahri, T | 1 |
| Burgers, JM; Carde, P; de Wolf-Peeters, C; Duez, N; Glabbeke, MV; Meerwaldt, JH; Monconduit, M; Sizoo, W; Somers, R; Thomas, J | 1 |
2 review(s) available for arginine and Brill-Symmers Disease
| Article | Year |
|---|---|
Intensified therapy followed by autologous stem-cell transplantation (ASCT) versus conventional therapy as first-line treatment of follicular lymphoma: a meta-analysis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Melphalan; Middle Aged; Neoplasms, Second Primary; Prednisone; Recombinant Proteins; Remission Induction; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine; Whole-Body Irradiation | 2013 |
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Longitudinal Studies; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prevalence; Prognosis; Recombinant Proteins; Survival Rate; Teniposide; Vincristine | 2007 |
8 trial(s) available for arginine and Brill-Symmers Disease
| Article | Year |
|---|---|
Long-term follow up of the FL2000 study comparing CHVP-interferon to CHVP-interferon plus rituximab in follicular lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Rituximab; Survival Rate; Teniposide; Time Factors; Young Adult | 2013 |
Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Proteins; Remission Induction; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de
Topics: Antineoplastic Combined Chemotherapy Protocols; Belgium; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; France; Humans; Interferon Type I; Lymphoma, Follicular; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Recombinant Proteins; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2006 |
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon-alpha; Lymphoma, Follicular; Macrophages; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Rituximab; Survival Rate; Teniposide; Treatment Outcome | 2008 |
Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; Cyclophosphamide; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Recombinant Proteins; Regression Analysis; Survival Rate; Teniposide | 1993 |
Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prognosis; Recombinant Proteins; Survival Analysis; Teniposide | 1998 |
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: a GELA study. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Interferons; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Prednisone; Prognosis; Survival Analysis; Teniposide; Vidarabine | 1999 |
Low-dose total body irradiation versus combination chemotherapy for lymphomas with follicular growth pattern.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Prospective Studies; Random Allocation; Teniposide; Whole-Body Irradiation | 1991 |
5 other study(ies) available for arginine and Brill-Symmers Disease
| Article | Year |
|---|---|
Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.
Topics: Arginine; Disease Progression; Female; Humans; Lymphoma, Follicular; Male; Mutation; Neoplasm Staging; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-mdm2; Survival Rate; Tumor Suppressor Protein p53 | 2009 |
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Graft Rejection; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Lymphoma, Follicular; Melphalan; Middle Aged; Pancytopenia; Podophyllotoxin; Prednisone; Prognosis; Teniposide; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Decision Making; Doxorubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Quality-Adjusted Life Years; Recombinant Proteins; Survival Analysis; Teniposide | 1998 |
Low-grade stage III-IV follicular lymphoma: multivariate analysis of prognostic factors in 484 patients--a study of the groupe d'Etude des lymphomes de l'Adulte.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Teniposide | 1999 |
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunocompromised Host; Interferon-alpha; Lymphoma, Follicular; Opportunistic Infections; Prednisone; Salvage Therapy; Teniposide; Toxoplasmosis, Cerebral; Vidarabine | 2002 |